Know Cancer

or
forgot password

Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy


Phase 4
18 Years
80 Years
Open (Enrolling)
Female
Pain, Breast Cancer

Thank you

Trial Information

Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy


Inclusion Criteria:



- Mastectomy in patients 18 to 80 years old

Exclusion Criteria:

- American Society of Anesthesiology (ASA) class >= 3

- Renal, heart or hepatic failure

- Allergy to ketalar

- Psychiatric disease

- Chronic antalgic treatment

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Outcome Measure:

To evaluate the effect of perioperative ketalar on pain intensity 3 months after a mastectomy

Principal Investigator

Vincent PIRIOU, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Hospices Civils de Lyon

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

2004.349

NCT ID:

NCT00129597

Start Date:

December 2004

Completion Date:

Related Keywords:

  • Pain
  • Breast Cancer
  • Ketalar
  • NMDA
  • mastectomy
  • postoperative chronic pain
  • Chronic pain after mastectomy for breast cancer
  • Breast Neoplasms

Name

Location